Redeye comments on Carasent’s Q1 report, showing solid ARR growth yet somewhat higher OPEX. We keep a positive view of Carasent and expect minor adjustments to our forecasts and Base Case.
ANNONS
Redeye comments on Carasent’s Q1 report, showing solid ARR growth yet somewhat higher OPEX. We keep a positive view of Carasent and expect minor adjustments to our forecasts and Base Case.